Patents Assigned to MERCK PATENT CESELLSCHAFT MIT BESCHRANKTER HAFTUNG
  • THIENOPYRIMIDINES
    Publication number: 20110028472
    Abstract: Novel thienopyrimidines of the formula (I), in which R1, R2 and X have the meanings indicated in Claim 1, are inhibitors of TGF-beta receptor kinase, and can be employed, inter alia, for the treatment of tumours.
    Type: Application
    Filed: March 23, 2009
    Publication date: February 3, 2011
    Applicant: MERCK PATENT CESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Guenter Hoelzemann, Hartmut Greiner, Christiane Amendt, Frank Zenke